RERDS – Centre for Pharmaceutical Research (CPR)

RERDS – Centre for Pharmaceutical Research (CPR)

Sponsored by Raghavendra Educational and Rural Development Society
(Reg. No. 198/2002)

In view of developing Pharmaceutical Research in institution, RERDS constituted the “Centre for Pharmaceutical Research (CPR)” in the Research and Development Cell (R & D Cell) to offer Research and Training facilities.

Preamble

  • Functioning as a private non-profit organization, recognized as SIRO by DSIR in the year 2018.
  • In the Year 2010, it was started as Centre for Pharmaceutical Research (CPR) as annex to Raghavendra Institute of Pharmaceutical Education and Research (RIPER), but
  • From 2016, it is renamed as RERDS – Centre for Pharmaceutical Research (CPR) and functioning as independent organization with its own decentralized facility, faculty, vision and objectives vide RERDS society resolution.

Research Vision

“Committed to excel in the area of basic and pharmaceutical research, critically to resolve social and public problems through technological innovations and global collaborations”.

Quality Policy

We committed ourselves to shape the basic and pharmaceutical research as translating research and innovations for a better society through global partnership and continuous improvement.

Objectives

  • To perform collaborative and translational research and development for delivering new pharmaceuticals / products as preventive / curative ailments against life threatening diseases.
  • To undertake collaborative research projects with the goal of a seamless transition of therapeutic molecules to clinical stages and beyond.
  • To conduct programme / training relevant to societal needs, advancement in research techniques for the academia and industrial personnel engaged in the Quality Pharmaceutical deliverables.
  • To facilitate a platform for the researchers towards their development in innovative research, collaborations, patent filing and publications.
  • To frame stable platform with reputed research organization and Universities from India and abroad on productive research and product development on the context of mutual benefits.

RERDS-CPR – Organization Chart

RERDS-CPR – Research Advisory Board

Name Designation Address
Ex-Officio Member Director R&D JNTUA, Anantapur
Prof. C. Kokate Ex Vice-Chancellor KLE University, Belgaum, Karnataka
Prof. B. Suresh Vice-Chancellor JSS University, Mysore, Karnataka.
Prof N Udupa Professor Department of Pharmacy Management, Manipal University, Manipal,  Karnataka
Prof K.B. Chandrasekhar Vice-Chancellor Krishna University, Machilipatnam, Andhra Pradesh
Dr. Devanna Director and Professor JNTUA, Anantapur, Andhra Pradesh
Dr G N Sastry Senior Scientist Senior Scientist, IICT, Hyderabad, Telangana.
Dr Bontha  Veera raju babu Scientist F Indian Council for Medical Research, New Delhi.
Dr U Ramesh Scientist Indian Institute of Chemical Technology (IICT), Hyderabad.
Dr Azger Dusthackeer VN Scientist – Bacteriologist National Institute of Research in Tuberculosis (NIRT), Chennai.
Dr KVSR Prasad Retired Professor Professor in pharmacology, Mahila University, Tirupati, Andhra Pradesh.
Dr A Pramila Rani Principal University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur Dist., Andhra Pradesh.
Dr Dina Nair Scientist (Medical) National Institute of Research in Tuberculosis (NIRT), Chennai
Dr CH V Rao Principal Scientist Pharmacology Division, National Botanical Research Institute, India
Dr Amit Tiwari Principal Scientist Cancer Biology, The University of Toledo, USA
Dr. Sarangapani Former Professor Kakatiya University, Warangal, Telangana.
Dr T K Ravi Principal & Professor College of Pharmacy, SRIPMS, Coimbatore, Tamil Nadu.
Dr H G Shiva Kumar Principal & Professor College of Pharmacy, JSS University, JSS University, Mysore, Karnataka.

 

 Animal Ethical Committee approved by CPCSEA, Govt. of India (Twice in a Year)

Name and designation Address Nominated as
Dr. C. Madhava Reddy Room No 124, Sir CV Ram Science Building, Deptt of Biotechnology and Bioinformatics, Yogi Verma University, Kadapa – 516005, AP

Contact No: 9703599690

Email: cmadhavareddy@gmail.com

 Main Nominee
Dr. Thavitiki Prasad Rao, Assistant Professor, Dept of Veterinary Science, Gopavaram, Proddatur – 516360, Kadapa, Andhra Pradesh.

Contact No: 9866903250

 Link Nominee
Dr. C. Rajaram

 

 

 Memorial College of Pharmacy, 44/35 – 1, Prakruthi Nagar, Utukur, Kadapa – 516003

Contact No: 9642780790

Email: rajaram212121@gmail.com

 Scientist from outside the Institute
Dr. A. Hari Krishna 1 – 68-6, Rajendra Prasad Steet, Kadiri 515591, Ananthapuramu Dist, Andhra Pradesh

Contact No: 9497354033

Email: hkagisam@gmail.com

 Social aware Nominee
Dr. Y. Padmanabha Reddy

Principal

 Raghavendra Inst. of Pharm. Education and Research

Email: ypreddyatp@gmail.com

 Scientist from different biological discipline, chairperson (Chairperson)
Dr. K. Somasekhar Reddy

Asso. Professor

 Raghavendra Inst. of Pharm. Education and Research

Email:somu.reddyvaru@gmail.com

 

 Scientist In-charge of Animal Hose Facility
Dr. B Pradeepkumar

Asso. Professor

 Raghavendra Inst. of Pharm. Education and Research

Email:bhupalampradeep@gmail.com

 

 Biological Scientist
Dr. Vijay R Chidrawar

Professor – Director, R&D

 Raghavendra Inst. of Pharm. Education and Research

Email:vijay_pharmacology@yahoo.com

 Scientist from different discipline
Dr. P. Swetha Raghavendra Inst. of Pharm. Education and Research Veterinarian

 RERDS-CPR – Research Review Committee

With reference to the promotion of quality research work in the institution, the following members are nominated as members of the reconstituted Research Review Committee with their respective position. This committee shall be effective from 04.04.2022 to till further orders.

S. No Name Designation Nominated Position
1 Dr. Y. Padmanabha Reddy Principal Chairman
2 Dr. Vijay R Chidrawar Director (R&D Division) Secretary
3 Dr. M. Vijaya Jyothi Research Co-ordinator Coordinator
4 Dr. V. Uma Maheshwara Rao Director (Academics) Member
5 Dr. H. Abdul Ahad Professor Member
6 Dr. Nawaz Mohammed Asso. Professor Member
7 Dr. C. Haranath Asso. Professor Member
8 Dr. K. Somasekhar Reddy Asso. Professor Member
9 Dr. K. Vinod Kumar Asso. Professor Member
10 Dr. B. Pradeep Kumar Asso. Professor Member
11 Dr. Vinod Kumar Nelson Asso. Professor Member

 Note:

  • The above committee shall also be acting as Doctoral Committee for the review of PhD works / or any research matters / whenever required by the Principal / University.
  • Research Advisory Board (RAB) shall be assisting the RRC, whenever required.
  • Meetings and resolutions can be made when 70% of members are present.

 Various Units / Research Division under RERDS-CPR

Research Team

Name & Qualification  Designation
Dr. Y. Padmanabha Reddy., M. Pharm., PhD., FIC President / CEO, RERDS – CPR
Dr. Vijay R Chidrawar., M. Pharm., PhD Director, RERDS – CPR
Dr. K. Somasekhar Reddy., M. Pharm., PhD Head, Pharmacology & Toxicology Division
Dr. M. Vijaya Jyothi, M. Pharm., PhD Head, Molecular Modelling & Drug Discovery Division
Dr. Vinod Kumar Nelson., M. Pharm., PhD Head, Phytomedicine & Phytochemistry Division
Dr. Hindustan Abdul Ahad, M. Pharm., PhD., FAGE Head, Formulation & Drug Delivery Division
Dr. B. Pradeep Kumar., M. Pharm., PhD Scientist, Pharmacological screening and animal ethical clearance
Mr. C. Naresh Babu., M. Pharm., Research Associate
Mr. E. Bhargav, M. Pharm., Research Associate
Mrs. B. Nagasubha, M. Pharm., Research Associate
Mr. P. Chiranjeevi, M. Pharm., Research Associate
Mrs. S. Triveni, M. Pharm., Research Associate
Mrs. Y. Sravani, M. Pharm., Research Associate
Mr. S. Mahaboob Basha., B.Sc, D. Pharm., Purchase and Store keeping

 Consultancy /Internal Revenue Policy with reference to the promotion of consultancy works, the following are the framed internal revenue / Consultancy Policies, till further notice.

  • There should be letter from customer (Researchers /PhD scholars/Industry/Institution) addressed to the principal.
  • The Principal shall forward the letter to R & D director.
  • R&D Division shall fix the charges as per our norms in consultation with Heads.
  • Then copy of the letter and requirement shall be forwarded to the Concern Heads. Then Head shall allot the work to Skill assistants.
  • Once the report is ready, the duly signed report shall be forwarded to R&D.
  • The Report will be dispatched / issued to applicant, once the payment is cleared.
  • All the details of Reports / amount will be entered in register / duly counter signed by principal.
  • The copy of facility request letter shall also be documented in Concern department.

Term & Conditions

  • There should not be any hidden work /unethical report to customer without the knowledge of Head & R&D Director. In such cases, serious action will be executed at the discretion of Principal.
  • If any faculty/Scholars invite consultancy work, 10% of the total cost charged will paid as Reward.

 Research Activity – Ethical Clearance Procedure

The following shall be the procedure for conducting experiments on Animals /Human subjects,

  • Study involving Human /Animal subjects should not be initiated until the ethical clearance is issued by R&D Division.
  • There shall be only one Animal ethical committee meeting and One Human Ethical Review Board meeting during the one academic year (July 1st to June 31st).
  • However, in case of emergency, the protocol may be mailed to Nominee and the decision is at the discretion of Chairman and Govt. Nominee.
  • During Ethical clearance meeting, the principal investigator / Co-investigator / Students must be available to defend the queries.
  • All investigators must give proposal presentation and submit the copy of PPT for signing along with the prescribed format of application.
  • All UG Projects / experiments should be designed in such a way that no animal is allowed to sacrifice.
  • Animals will be allowed to dissect only in PG / Granted Projects.
  • The copy of animal ethical committee approval letter must be submitted to pharmacology department to touch /use animals.
  • In case of human subjects, interventions should be as per the directions of ethical committee and should not violate GLP / GCP.

Indent of chemicals / supply of chemicals to Research

(Applicable for: M. Pharm / B. Pharm Projects, Grants)

With reference to the promotion of research works, the following are the framed Policies, till further notice.

Step 1 A student / scholar shall prepare a list of chemicals for their research along with the research title and protocol number (if) and get signed by their supervisor
Step 2 The signed letter shall be forward to the R&D through HOD with remarks, HOD should write the comments on chemicals if it is project specific, and its importance/ if belongs to consultancy/funded.
Step 3 The R&D division will forward the letter with the comment to the concern section through Principal / Academic coordinator. The copy the letter shall be retailed by the HOD.
Step 4 The HOD shall ask concern lab assistant to submit the Indent for the same in prescribed format.
Step 5 The Lab assistant shall follow up with store keeper for placing and procuring chemicals.
Step 6 Once the chemicals are received from the store, Lab assistant shall enter in their department stock resister / distribution register.
Step 7 Then chemicals shall be supplied to students /scholars, Student shall hold the responsibility of submitting the unused chemicals to lab assistant with utilization record /job record.

NOTE:

  • No students are allowed in the purchase and permission process.
  • If any project specific chemicals, R&D and HOD shall decide to supply or not to supply.
  • In case research/project belongs to consultancy / UGC/AICTE /etc funded, all chemicals shall be supplied by the institute Plagiarism Policy.
Applicable to B. Pharm Project book,
M. Pharm Dissertation book,
Pharm D Clerkship book & Internship book
PhD thesis,
Reference As required by JNTUA, other Regulatory systems
% Plagiarism allowed B. Pharm (up to 40%)
M. Pharm / Pharm D as per JNTUA Norms (up to 30%)
For PhD it may change depends on university.

Procedure:

  • With reference to the above cited information regarding plagiarism policy, I request all faculty members TO SIGN THE RESEARCH REPORT only after obtaining plagiarism report from R&D Division, RIPER.
  • The student/Scholar shall submit the document (word document) in a USB /Pen-drive to R&D COORDINATOR for plagiarism report. See that the document is EXCLUDED from contents like, reference, Index, acknowledgement, definitions, abbreviations, list of tables, list of figures, and certificates.
  • The certificate of plagiarism will be issued by R&D and need to be enclosed in dissertation /thesis/project/internship/clerkship books

Instructions to reduce plagiarisms

    • Concise the introduction to 10-15 pages only, but focus on importance, need, challenges, risk, applicability, current trends based write up relating the area of your research.
    • Definitions and abbreviations may be added as annexure, which do not need plagiarism.
    • Compile the content from several resources.
    • Include pictures, graph, images wherever possible instead a paragraph explanation.
    • Rewrite all text with change in phrase, verb, and sentence forms.
    • Literature – do not paste abstract, make it table form, or write 3-5 sentence on each literature.
    • Try to arrange flow chart / pert chart based procedure in the methodology/experimental part.
    • Result and discussion should be own written.
    • Do not copy any content from old research report.

RERDS-CPR Infrastructure

Name of the facility Area
Director office (RERDS-CPR) /Discussion Room 430 sq ft
Molecular Modelling & Drug Discovery Laboratory 968 sq ft
Sophisticated Analytical Instrumentation Facility 1022 sq ft
Pharmacology & Toxicology Laboratory  807 Sq ft
Phytomedicine & Phytochemistry Laboratory 807 Sq ft
Central facility – DST FIST supported 807 Sq ft
Formulation & Drug Delivery (Pilot Plant ) Laboratory 914 sq ft
CPCSEA Approved Animal House 753 Sq ft
Store Room 355 Sq ft
Library 600 Sq. Ft

 

  1. Major Equipment /facility – Molecular modelling & Drug Discovery Laboratory
Name of the facility Make Number
Molecular Docking software Schrodinger,

AutoDock,

Chimera,

Discovery studio

 01

01

01

01
QSAR Build QSAR 01
Rotary evaporator Aditya 02
Parallel Synthesizer Radleys 12 plus 01
Vacuum dryer Thermo 01
Hot plates Remi 02
Hot air Oven Remi 02
TLC plate /assembly Borosilicate Adequate
Column chromatography for purification Borosilicate 02

 

Current Research areas

  • Synthesis & Purification of organic molecules
  • Study of Physicochemical properties
  • Molecular Docking studies
  • ADMET prediction – Lead Optimization
  • Design of Experiments by Quality by Design

 

  1. Major Equipment /facility – Formulation and Drug Delivery (Pilot Plant) Laboratory
Name of the facility Make Number
Rotary Tablet Machine (GMP Model) Rimek 01
Dissolution Apparatus (Oral Delivery) Electro Lab 01
Diffusion cell Apparatus (Transdermal Delivery) Orchid 01
Disintegration Apparatus Electro Lab 01
Brookfield Viscometer Amkette 01
Nano particle and Zeta potential Analyser Horiba 01
All-purpose Equipment (Coating, Granulator, Mixer) Orchid 01
Moisture Analyser Fabricated 01
Tray dryer Thermo 01
Double cone blender Remi 05
Hot air Oven Remi 02
Rota evaporator Borosilicate 01
HPLC Elico 01
UV-Visible Spectrometer Shimadzu 01

 Current Research areas

  • Development and characterization of nano formulations by applying Quality by Design (QbD) principles for various objectives like solubility & stability enhancement of API, targeting to various organs.
  • Design and fabrication of various types of tablets to tailor the drug release.
  • Design and fabrication of drug delivery systems to treat cerebral malaria and cancer.

 

  1. Major Equipment /facility – Sophisticated Analytical Instrumentation Facility
Name of the facility Make Number
HPLC (Binary Pump with PDA detection) Waters 01
HPLC (Binary Pump with PDA detection) Agilent 01
HPLC (Isocratic with UV-VWD) Agilent 01
Flash LC System Analyx 01
FT-IR (KBR & ATR techniques) Bruker 01
GC-FID Bruker 01
UV-Visible Double Beam Spectrophotometer LAB India 01
ELISA Reader Thermo Scientific 01
Lyophilizer Cintex 01
Environmental Chamber (Stability Studies) REMI 01
Cooling Incubator REMI 01
pH meter Elico 02
Conductivity meter Elico 01
Karl Fisher Auto titrator Elico 01
Colorimeter Elico 01

Current Research areas

  • Analytical method development by using HPLC, GC & UV-Vis spectrophotometer.
  • Stability studies for pharmaceuticals and dosage forms by HPLC
  • Impurity profiling and impurity characterization by HPLC
  • Spectral studies by using FT-IR & UV spectroscopy.
  • Analytical QbD
  1. Major Equipment /facility – Pharmacology & Toxicology Laboratory
Name of the facility Make Number
Spectrophotometer/Fluorometer DS-11FX+ Denovix 01
Semi Auto Analyzer Erba 01
Digital Plethysmometer Inco 01
Digital Physiograph Inco 01
Tissue Homogenizer Remi 01
Swim Test Apparatus Inco 01
Metabolic cage Inco 01
Actophotometer Inco 01
Pole Climb Response Apparatus Inco 01
Digital Thermometer Inco 01
Digital Rotating Drum Orchid 02
Digital Organ Bath Orchid 02
Centrifuge Remi 01
Elevated Plus maze Fabricated 01
Hole Board Fabricated 01
Stair Case Fabricated 01
Y – Maze Fabricated 01

Current Research areas

  • Cancer,
  • Neurodegenerative disorders
  • Behavioural diseases,
  • Gastrointestinal diseases,
  • Autoimmune diseases,
  • Cardio metabolic syndrome,
  • Heamatological diseases,
  • Inflammatory diseases,
  • Infectious diseases.
  1. Major Equipment /facility – Phytomedicine & Phytochemistry Laboratory
Name of the facility Make Number
Soxhlet Apparatus Borosilicate 02
Clevenger’s Apparatus Borosilicate 04
Column Chromatography Borosilicate 02
TLC Mason technology 01
UV Cabinet Thomas scientific 01
Rotavap (Shared) Buchi 01
Hot air oven Remi 01
Flash LC System (Shared) Analyx one 01

Current Research areas

  • Extraction of Phytochemical constituents from plant sources.
  • Preliminary identification tests
  • Isolation or Separation of active constituents.